Filter trials by:
Indication
- Back and/or Leg Pain
- Chronic Trunk and/or Limb Pain
- CRPS
- Fibromyalgia
- Healthy
- Knee Osteoarthritis
- Migraine
- Neck / Upper Limb Pain
- Neuropathic Pain
- Nonalcoholic Fatty Liver Disease
- Osteoporosis
- Other
- Overactive Bladder
- Pain – General
- Painful Diabetic Neuropathy
- Postherpetic Neuralgia
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Spondyloarthritis
Phase / Stage
Clinical Trials – Musculoskeletal
Our clinical research team has vast experience in musculoskeletal conditions. Our primary indication for this area of medical development is in osteoarthritis clinical trials.
Please see study list below for musculoskeletal clinical trials that have been conducted at Genesis Research Services.
A Multi centre, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated with Osteoarthritis in the Knee.
- Year: 2015
- Type: Musculoskeletal
- Phase: III
- Indication: Knee Osteoarthritis
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee.
- Year: 2016
- Type: Musculoskeletal
- Phase: III
- Indication: Knee Osteoarthritis
A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Knee Osteoarthritis Associated with Bone Marrow Lesions.
- Year: 2016
- Type: Musculoskeletal
- Phase: IIa
- Indication: Knee Osteoarthritis
A randomised, double-blind using blinded evaluator, placebo and active controlled, pilot study to evaluate the safety and efficacy of intra articular administration of Articul One in patient with symptomatic primary knee osteoarthritis.
- Year: 2017
- Type: Musculoskeletal
- Phase: II
- Indication: Knee Osteoarthritis
A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Multiple Center, Multiple-Dose Study to Assess the Efficacy and Safety of ZYN002 Administered as a Transdermal Gel to Patients with Knee Pain due to Osteoarthritis.
- Year: 2017
- Type: Musculoskeletal
- Phase: IIa
- Indication: Knee Osteoarthritis
A Phase IIa, Randomized, Double-blinded, Placebo-controlled, Dose-finding Study for Single-Dose Administration of TLC599 in Patients with Osteoarthritis (OA) of Knee.
- Year: 2017
- Type: Musculoskeletal
- Phase: IIa
- Indication: Knee Osteoarthritis
A Phase 3, Randomized, Double-blind, Placebo- and Active controlled Study to Evaluate the Efficacy and Safety of TLC599 in Patients with Osteoarthritis of the Knee.
- Year: 2020
- Type: Musculoskeletal
- Phase: III
- Indication: Knee Osteoarthritis